ArticleBMC neurology2025

Impact of anti-CGRP monoclonal antibodies on treatment satisfaction and quality of life in patients with resistant migraine: a retrospective real-world study.

Laura Cardona-Roca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.